• Twitter
  • Linkedin
  • Careers
  • News
  • Contact
Amplyx
  • Who We Are
  • Our Focus
  • Our Pipeline
  • Patient Community
  • Investors
  • Menu
2020, latest news 1, Press Release

Amplyx Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting

Read more
December 3, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-12-03 05:08:352020-12-03 05:08:35Amplyx Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting
2020, latest news 1, Press Release

Amplyx to Present New Clinical and Preclinical Data for its Two Lead Programs at Upcoming Scientific Conferences

Read more
October 16, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-10-16 04:05:252020-10-16 04:05:25Amplyx to Present New Clinical and Preclinical Data for its Two Lead Programs at Upcoming Scientific Conferences
2020, latest news 1, Press Release

Amplyx to Participate in Upcoming Antifungal Webinar Presented by Maxim Group LLC

Read more
September 14, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-09-14 06:03:432020-09-14 06:03:43Amplyx to Participate in Upcoming Antifungal Webinar Presented by Maxim Group LLC
2020, latest news 1, Press Release

Amplyx Doses First Patient in Phase 2 Clinical Trial of Anti-BKV Monoclonal Antibody in Renal Transplant Recipients

Read more
August 17, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-08-17 04:02:372020-08-17 04:02:37Amplyx Doses First Patient in Phase 2 Clinical Trial of Anti-BKV Monoclonal Antibody in Renal Transplant Recipients
2020, latest news 2, Press Release

Amplyx Pharmaceuticals Announces Participation in Multiple Upcoming Investor Conferences

Read more
August 5, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-08-05 04:01:542020-10-16 11:39:08Amplyx Pharmaceuticals Announces Participation in Multiple Upcoming Investor Conferences
2020, latest news 2, Press Release

Amplyx Announces Positive Top-line Data in Phase 2 Clinical Trial of Novel Antifungal Fosmanogepix

Read more
July 22, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-07-22 13:53:452020-10-16 11:38:50Amplyx Announces Positive Top-line Data in Phase 2 Clinical Trial of Novel Antifungal Fosmanogepix
2020, Press Release

Amplyx Pharmaceuticals to Present at the Upcoming Virtual European Biotech Investor Day 2020

Read more
June 24, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-06-24 04:09:222020-10-16 11:39:41Amplyx Pharmaceuticals to Present at the Upcoming Virtual European Biotech Investor Day 2020
2020, latest news 2, Press Release

Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million

Read more
May 19, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-05-19 04:03:292020-08-18 13:48:12Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
2020, Press Release

Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix

Read more
May 19, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-05-19 04:02:492020-08-18 13:49:26Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix
2020, Press Release

Amplyx Pharmaceuticals to Participate in Antifungal Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector

Read more
April 29, 2020/by ksmith
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 ksmith https://amplyx.com/wp-content/uploads/2019/11/logo.svg ksmith2020-04-29 04:02:332020-08-18 13:49:36Amplyx Pharmaceuticals to Participate in Antifungal Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
Page 1 of 3123
Amplyx © Copyright 2021 Privacy Policy EU Privacy Policy
Scroll to top